Skip to main content

Gout: Serum Urate Target (Recommended for eMeasure Trial Approval)

CBE ID
2549e
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 and older with a diagnosis of gout treated with urate-lowering therapy (ULT) for at least 12 months, whose most recent serum urate result is less than 6.8 mg/dL.